JP2015520161A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015520161A5 JP2015520161A5 JP2015512644A JP2015512644A JP2015520161A5 JP 2015520161 A5 JP2015520161 A5 JP 2015520161A5 JP 2015512644 A JP2015512644 A JP 2015512644A JP 2015512644 A JP2015512644 A JP 2015512644A JP 2015520161 A5 JP2015520161 A5 JP 2015520161A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- mammal
- nucleic acid
- aav
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261648801P | 2012-05-18 | 2012-05-18 | |
| US61/648,801 | 2012-05-18 | ||
| PCT/US2013/031725 WO2013172964A1 (en) | 2012-05-18 | 2013-03-14 | Methods and compositions for treating amyloid deposits |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018207331A Division JP2019031564A (ja) | 2012-05-18 | 2018-11-02 | アミロイドの沈着を処置するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015520161A JP2015520161A (ja) | 2015-07-16 |
| JP2015520161A5 true JP2015520161A5 (https=) | 2016-05-12 |
| JP6469000B2 JP6469000B2 (ja) | 2019-02-13 |
Family
ID=49584137
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015512644A Active JP6469000B2 (ja) | 2012-05-18 | 2013-03-14 | アミロイドの沈着を処置するための方法および組成物 |
| JP2018207331A Pending JP2019031564A (ja) | 2012-05-18 | 2018-11-02 | アミロイドの沈着を処置するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018207331A Pending JP2019031564A (ja) | 2012-05-18 | 2018-11-02 | アミロイドの沈着を処置するための方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20150183850A1 (https=) |
| EP (1) | EP2850195B1 (https=) |
| JP (2) | JP6469000B2 (https=) |
| CN (2) | CN112574964A (https=) |
| AU (1) | AU2013263346B2 (https=) |
| BR (1) | BR112014028666B1 (https=) |
| CA (1) | CA2873890C (https=) |
| ES (1) | ES2786078T3 (https=) |
| HK (1) | HK1207109A1 (https=) |
| IN (1) | IN2014KN02672A (https=) |
| RU (1) | RU2673484C2 (https=) |
| WO (1) | WO2013172964A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119876138A (zh) | 2014-11-14 | 2025-04-25 | 沃雅戈治疗公司 | 调节性多核苷酸 |
| US11027024B2 (en) | 2015-05-29 | 2021-06-08 | University Of Iowa Research Foundation | Methods of delivery of transgenes for treating brain diseases |
| WO2016198627A1 (en) * | 2015-06-12 | 2016-12-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical composition for the treatment of alzheimer's disease |
| WO2017179646A1 (ja) * | 2016-04-14 | 2017-10-19 | Ｔａｏヘルスライフファーマ株式会社 | アミロスフェロイド（ａｓｐｄ）様構造体及び医薬組成物 |
| CA3024448C (en) | 2016-05-18 | 2025-09-09 | Voyager Therapeutics, Inc. | MODULATING POLYNUCLEOTIDES |
| EP3506927A4 (en) | 2016-08-03 | 2020-05-06 | University of South Florida | REELIN COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASES |
| WO2018045347A1 (en) * | 2016-09-02 | 2018-03-08 | Spark Therapeutics, Inc. | Methods and vectors for treating cns disorders |
| EP3309550A1 (en) * | 2016-10-12 | 2018-04-18 | sphingotec GmbH | Method for the detection of apolipoprotein e4 |
| BR112020006671A2 (pt) | 2017-10-03 | 2020-12-01 | Prevail Therapeutics, Inc. | terapias genéticas para distúrbios lisossômicos |
| KR102709597B1 (ko) | 2017-10-03 | 2024-09-26 | 프리베일 테라퓨틱스, 인크. | 리소좀 장애를 위한 유전자 요법 |
| JP7616995B2 (ja) * | 2018-11-28 | 2025-01-17 | プリベイル セラピューティクス，インコーポレーテッド | 神経変性疾患のための遺伝子治療 |
| EP4045653A1 (en) * | 2019-10-16 | 2022-08-24 | Cornell University | Gene therapy for alzheimer's disease |
| WO2021197396A1 (zh) * | 2020-03-31 | 2021-10-07 | 挪贝肽医药科技(上海)有限公司 | 氘代氧化苯砷化合物及其应用 |
| KR20230112672A (ko) * | 2020-11-25 | 2023-07-27 | 프리베일 테라퓨틱스, 인크. | 신경변성 질환을 위한 유전자 요법 |
| WO2023108507A1 (en) * | 2021-12-15 | 2023-06-22 | National Institute Of Biological Sciences, Beijing | Recombinant aav vectors and use thereof |
| CN116063405B (zh) * | 2022-09-27 | 2025-08-29 | 广州译码基因科技有限公司 | 可提高AAV病毒包装能力的衣壳蛋白突变体MutC及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5589154A (en) * | 1994-11-22 | 1996-12-31 | Rutgers, The State University Of New Jersey | Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease |
| US6436996B1 (en) * | 1997-09-30 | 2002-08-20 | Duke University | Modulation of nitric oxide production |
| US6855314B1 (en) | 2000-03-22 | 2005-02-15 | The United States Of America As Represented By The Department Of Health And Human Services | AAV5 vector for transducing brain cells and lung cells |
| US6468524B1 (en) * | 2000-03-22 | 2002-10-22 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | AAV4 vector and uses thereof |
| GB0322645D0 (en) * | 2003-09-26 | 2003-10-29 | Melacure Therapeutics Ab | Use of antisecretory factor peptides |
| EP1828390B1 (en) * | 2004-12-15 | 2012-06-13 | The University Of North Carolina At Chapel Hill | Chimeric vectors |
| PL1879623T3 (pl) * | 2005-05-02 | 2013-03-29 | Genzyme Corp | Terapia genowa zaburzeń rdzenia kręgowego |
| US9155749B2 (en) * | 2006-09-14 | 2015-10-13 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
| EP2154969B1 (en) * | 2007-05-16 | 2015-11-18 | The Brigham and Women's Hospital, Inc. | Treatment of synucleinopathies |
| EP2561075B1 (en) * | 2010-04-23 | 2018-06-27 | University of Massachusetts | Aav-based treatment of cholesterol-related disorders |
-
2013
- 2013-03-14 JP JP2015512644A patent/JP6469000B2/ja active Active
- 2013-03-14 RU RU2014151218A patent/RU2673484C2/ru active
- 2013-03-14 IN IN2672KON2014 patent/IN2014KN02672A/en unknown
- 2013-03-14 HK HK15107526.1A patent/HK1207109A1/xx unknown
- 2013-03-14 AU AU2013263346A patent/AU2013263346B2/en active Active
- 2013-03-14 BR BR112014028666-3A patent/BR112014028666B1/pt active IP Right Grant
- 2013-03-14 US US14/402,064 patent/US20150183850A1/en not_active Abandoned
- 2013-03-14 CA CA2873890A patent/CA2873890C/en active Active
- 2013-03-14 EP EP13790429.8A patent/EP2850195B1/en active Active
- 2013-03-14 WO PCT/US2013/031725 patent/WO2013172964A1/en not_active Ceased
- 2013-03-14 ES ES13790429T patent/ES2786078T3/es active Active
- 2013-03-14 CN CN202011133829.0A patent/CN112574964A/zh active Pending
- 2013-03-14 CN CN201380038140.1A patent/CN104540952A/zh active Pending
-
2018
- 2018-11-02 JP JP2018207331A patent/JP2019031564A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015520161A5 (https=) | ||
| RU2014151218A (ru) | Способы и композиции для лечения амилоидных отложений | |
| Yousefi Dehbidi et al. | Mesenchymal stem cells and their derived exosomes to combat Covid–19 | |
| JP2016500648A5 (https=) | ||
| JP2015518818A5 (https=) | ||
| EA201500802A1 (ru) | Способы профилактики и/или лечения кардиомиопатии и устранения симптомов кардиомиопатии, фармацевтическая композиция, векторы | |
| EP4378487A3 (en) | Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues | |
| EA201590353A1 (ru) | Способы лечения болезни альцгеймера и фармацевтические композиции | |
| WO2015158749A3 (de) | Viraler vektor für den zielgerichteten gentransfer in gehirn und rückenmark | |
| BR112015018252A2 (pt) | composição farmacêutica aquosa de dose fixa estável para administração nasal para um ser humano, composição de suspensão aquosa farmacêutica de dose fixa estável para administração nasal para um ser humano, suspensão estável adequada para administração nasal a um ser humano, método para tratar rinite em um ser humano necessitando do mesmo, uso da composição farmacêutica para administração nasal, método para liberar uma composição farmacêutica e kit | |
| PH12014500865A1 (en) | Compounds and methods for enhancing innate immune responses | |
| JP2015530404A5 (https=) | ||
| MA40057A (fr) | Traitement thérapeutique de maladie cutanée au moyen de micro-organismes cutanés commensaux recombinants | |
| MX2017012506A (es) | Composicion farmaceutica para la prevencion y tratamiento de enfermedades del ojo que contiene, como ingrediente activo, una proteina de fusion en la cual el peptido que penetra el tejido y la preparacion del factor de crecimiento endotelial antivascular se fusionan. | |
| MX2021006253A (es) | Terapias génicas para enfermedad neurodegenerativa. | |
| JP2014513952A5 (https=) | ||
| JP2018509388A5 (https=) | ||
| BR112019009074A2 (pt) | composições, métodos e uso de transferência genética para o tratamento de doenças neurodegenerativas | |
| JP2015514115A5 (https=) | ||
| EA201491513A1 (ru) | Рекомбинантные штаммы escherichia coli | |
| McCall et al. | Pathogen-inspired drug delivery to the central nervous system | |
| RU2015128078A (ru) | Композиции и способы лечения рака мозга | |
| EA201991015A1 (ru) | Модифицированные пептиды | |
| PH12015502128A1 (en) | Novel dosing regimens of celgosivir for the treatment of dengue | |
| EA202090802A1 (ru) | Пептидная композиция для лечения повреждений, связанных с возбуждающей нейротоксичностью |